Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .

Essential

These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name econda
Purpose Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.
Statistics

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name econda
Purpose Statistics
External media

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name YouTube
Purpose Show YouTube content
Name Twitter
Purpose activate Twitter Feeds

Prof. Dr. Henri-Jacques Delecluse

Publications

Neuhierl B, Feederle R, Hammerschmidt H & Delecluse HJ.
Glycoprotein gp110 of Epstein-Barr virus determines viral tropism and efficiency of infection.
PNAS 2002, 99; 15036–15041

Timms JM, Bell A, Flavell J, Murray P, Rickinson A, Traverse-Glehen A, Berger F & Delecluse HJ.
Target cells of Epstein-Barr-virus (EBV)-positive post-transplant lymphoproliferative disease: similarities to EBV-positive Hodgkin's lymphoma
Lancet 2003, 361; 217-23

Feederle R, Shannon-Lowe C, Baldwin G, Delecluse HJ.
Defective infectious particles and rare packaged genomes produced by cells carrying terminal-repeat-negative Epstein-Barr virus.
J. Virol. 2005, 79; 7641-7

Shannon-Lowe CD, Neuhierl B, Baldwin G, Rickinson AB, Delecluse HJ.
Resting B cells as a transfer vehicle for Epstein-Barr Virus infection of epithelial cells.
PNAS USA 2006,103; 7065-7070

Granato M, Feederle R, Farina A, Gonnella R, Santarelli R, Hub B, Faggioni A and Delecluse HJ.
Deletion of Epstein-Barr virus BFLF2 leads to impaired viral DNA packaging and primary egress as well as to the production of defective viral particles.
J Virol. 2008 82:4042-51

Feederle R, Bannert H, Lips H, Müller-Lantzsch N, Delecluse HJ.
The Epstein-Barr virus alkaline exonuclease BGLF5 serves pleiotropic functions in virus replication.
J virol. 2009, 83:4952-62

Hutzinger R, Feederle R, Mrazek J, Schiefermeier N, Balwierz PJ, Zavolan M, Polacek N, Delecluse HJ*, Hüttenhofer A.
Expression and processing of a small nucleolar RNA from the Epstein-Barr virus genome.
PLoS Pathog. 2009 Aug;5(8):e1000547. *Corresponding author

Feederle R, Haar J, Bernhardt K, Linnstaedt SD, Bannert H, Lips H, Cullen BC & Delecluse HJ.
The members of a viral miRNA cluster co-operate to transform B lymphocytes.
J Virol. 2011 85(19):9801-10.

Feederle R, Linnstaedt SD, Bannert H, Lips H, Bencun M, Cullen BR, Delecluse HJ.
A Viral microRNA cluster strongly potentiates the transforming properties of a Human Herpesvirus.
PLoS Pathogens, 2011 PLoS Pathog 7(2): e1001294

to top
powered by webEdition CMS